2 completed, 1 withdrawn. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Withdrawn 1 |
Follow Lung Institute: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Crossover Blinded Trial of Cell Therapy Versus Placebo in COPD Treatment Then Placebo, Placebo Then Treatment - COPD, Emphysema or COPD | Not applicable | Withdrawn | Lung Institute | 2017-04-24 | 2018-09-13 | |
| An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease Cell therapy - COPD, Interstitial Lung Disease | Completed | Lung Institute | 489 | 2017-01-03 | 2021-04-27 | |
| Autologous Stem Cell Treatment for Chronic Lung Disease Study Cell therapy - COPD, Interstitial Lung Disease | Completed | Lung Institute | 207 | 2016-04-01 | 2018-10-15 |
Pulmonary Disease, Chronic Obstructive (3) · Dyspnea (2) · Lung Diseases, Interstitial (2) · Bronchitis, Chronic (1) · Emphysema (1)
Cell- and Tissue-Based Therapy (2)
United States (3)
Melissa Rubio, PhD (1) · Melissa Rubio, PhD, APRN (1)